Press Releases

American Stock Exchange Lists Common Stock of China Shenghuo Pharmaceuticals Holdings, Inc.

NEW YORK, June 14 /PRNewswire/ — The American Stock Exchange® (Amex®) today listed the common stock of China Shenghuo Pharmaceuticals Holdings, Inc. under the ticker symbol KUN.

China Shenghuo Pharmaceuticals Holdings, Inc. engages in the research, development, manufacture, and marketing of pharmaceutical, nutritional supplement and cosmetic products. Almost all of the products are derived from the medicinal herb Panax notoginseng, also known as Sanqi, Sanchi or Tienchi.

“We are pleased to welcome China Shenghuo Pharmaceuticals Holdings to the American Stock Exchange,” said John McGonegal, Senior Vice President Amex Equities Group. “An IPO is a great milestone for any company and we look forward to supporting Shenghuo Pharmaceuticals as it seeks to convey its value proposition to a greater number of investors.”

Mr. Gui Hua Lan, Chairman and CEO of China Shenghuo, said, “Listing on a well-respected, senior exchange such as the American Stock Exchange marks an important milestone in our drive to enhance investor awareness and increase shareholder value.”

The specialist in China Shenghuo Pharmaceuticals Holdings, Inc. will be Kellogg Capital Group LLC. For further information on KUN and other Amex- listed companies, please visit

The American Stock Exchange® (Amex®) offers trading across a full range of equities, options and exchange traded funds (ETFs), including structured products and HOLDRS(SM). In addition to its role as a national equities market, the Amex is the pioneer of the ETF, responsible for bringing the first domestic product to market in 1993. Leading the industry in ETF listings, the Amex lists 320 ETFs to date. The Amex is also one of the largest options exchanges in the U.S., trading options on broad-based and sector indexes as well as domestic and foreign stocks. For more information, please visit

About WestPark Capital, Inc.

WestPark Capital, Inc. is a full service investment banking and securities brokerage firm that serves the needs of both private and public companies worldwide, as well as individual and institutional investors. WestPark is committed to forging lasting partnerships with emerging growth companies and the investors who back them. WestPark’s approach is to provide customized financial solutions for virtually any need. A complete range of investment banking and brokerage services is available to corporate and individual clients. WestPark’s corporate finance professionals have the depth of experience and resources to create integrated financing solutions for both private and public marketplaces. Additionally, WestPark offers an exceptional array of private client services through its dedicated group of financial consultants. WestPark Capital understands the importance of strong relationships in today’s dynamic business environment and welcomes the opportunity to leverage this power into success for its customers. For more information visit

For further information, please contact:

Richard Rappaport
Anthony Pintsopoulos 
WestPark Capital, Inc. (310) 843-9300 
1900 Avenue of the Stars, Suite 310 
Los Angeles, CA 90067

International Locations*
Beijing, China
Shanghai, China
Hong Kong
Taipei, Taiwan